In a major decision, US pharma giant Eli Lilly and Company (India)...

Celltrion signs to buy Eli Lilly’s U.S. plant for USD 330 million

South Korea's Celltrion Inc. has signed an agreement to acquire Eli Lilly and Company's U.S. biopharmaceutical...

Lilly Partners with API to launch ‘Obesity Gurukul’

Eli Lilly and Company (India), in collaboration with the Association of Physicians of India (API), on Friday...

Tirzepatide tops semaglutide in trial

Eli Lilly and Company announced on Monday detailed results from SURMOUNT-5, a phase 3b open-label clinical trial,...

Lilly's orforglipron consistent with injectable GLP-1 medicines

According to an official statement from Eli Lilly and Company, "Orforglipron is the first oral small-molecule...

Eli Lilly launches Mounjaro in India for obesity, Type-2 diabetes

Approved by the Central Drugs Standard Control Organization (CDSCO), Mounjaro® is available in single-dose...

‘Eli Lilly’ pharma company planning to expand its research centre

India is emerging as an economic superpower, highlighted David Ricks, CEO, Eli Lilly, a pharmaceutical company,...

Eli Lilly, Cipla enter in partnership to enhance access to...

Mumbai (Maharashtra) [India], October 4 (ANI): Pharmaceutical firm Eli Lilly and Cipla entered into a strategic...

Eli Lilly's antibody cocktail drug gets emergency use nod in India

New Delhi [India], June 1 (ANI): Eli Lilly and Company India on Tuesday announced that it has received emergency use...

Lilly India gets nod for use of monoclonal antibody drugs for...

New Delhi [India], June 1 (ANI): Eli Lilly and Company India said on Tuesday it has received permission for...